NTLA Archived Articles
Intellia Therapeutics (NTLA): Pioneering Gene Editing Therapies to Transform Patient Care
Published on March 12, 2025
Intellia Therapeutics (NASDAQ:NTLA) - Pioneering the Next Generation of CRISPR-Based Therapies
Published on November 02, 2024
Intellia Therapeutics, Inc. (NASDAQ:NTLA): Pioneering the Next Generation of Gene Editing Therapies
Published on September 24, 2024